Effect of Esaxerenone, a novel mineralocorticoid receptor antagonist on insulin resistance in diabetic patients with hypertension.
Not Applicable
- Conditions
- Type 2 diabetes mellitus with hypertension
- Registration Number
- JPRN-UMIN000041326
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients treated with insulin 2. Patients treated with steroid 3. Patients with renal disfunction(eGFR<60) 4. Patients with hyperkalemia(K>5.0mEq/L) 5. Pregnant or nursing patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in M/I ratio from baseline at 6 months
- Secondary Outcome Measures
Name Time Method